title: Pathobiology of severe asthma.
abstract: Severe asthma (SA) afflicts a heterogeneous group of asthma patients who exhibit poor responses to traditional asthma medications. SA patients likely represent 5-10% of all asthma patients; however, they have a higher economic burden when compared with milder asthmatics. Considerable research has been performed on pathological pathways and structural changes associated with SA. Although limitations of the pathological approaches, ranging from sampling, to quantitative assessments, to heterogeneity of disease, have prevented a more definitive understanding of the underlying pathobiology, studies linking pathology to molecular markers to targeted therapies are beginning to solidify the identification of select molecular phenotypes. This review addresses the pathobiology of SA and discusses the current limitations of studies, the inflammatory cells and pathways linked to emerging phenotypes, and the structural and remodeling changes associated with severe disease. In all cases, an effort is made to link pathological findings to specific clinical/molecular phenotypes.
authors.affiliation: Department of Pathology.
authors.forename: Humberto E
authors.initials: HE
authors.lastname: Trejo Bittar
authors.forename: Samuel A
authors.initials: SA
authors.lastname: Yousem
authors.forename: Sally E
authors.initials: SE
authors.lastname: Wenzel
mesh_terms: D000818:Animals; D001249:Asthma / Q000473:pathology*; D006801:Humans; D010641:Phenotype
keywords: airway; epithelium; histology; inflammation; interleukins; pathology